Home/Filings/4/0001562180-19-002812
4//SEC Filing

Stimson Susan P 4

Accession 0001562180-19-002812

CIK 0001271214other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 6:27 PM ET

Size

12.6 KB

Accession

0001562180-19-002812

Insider Transaction Report

Form 4
Period: 2019-05-10
Stimson Susan P
Vice President, Marketing
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-10$13.05/sh+5,350$69,81841,332 total
  • Sale

    Common Stock

    2019-05-10$27.38/sh5,350$146,49835,982 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-105,3506,900 total
    Exercise: $13.05Exp: 2027-01-17Common Stock (5,350 underlying)
Footnotes (4)
  • [F1]Includes 21,969 Restricted Stock Units.
  • [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2019.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.52, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F4]The vesting commencement date of the option was March 1st, 2017. 1/8th of the shares subject to the option vested on September 1st, 2017 and 1/48th of the shares subject to the option vests monthly thereafter over 42 months.

Issuer

Intersect ENT, Inc.

CIK 0001271214

Entity typeother

Related Parties

1
  • filerCIK 0001614499

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 6:27 PM ET
Size
12.6 KB